West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
PLoS One. 2019 Jul 30;14(7):e0220533. doi: 10.1371/journal.pone.0220533. eCollection 2019.
Intensive follow-up after surgery for colorectal cancers is common in clinical practice, but evidence of a survival benefit is limited.
To conduct a systematic review and meta-analysis on the effects of follow-up strategies for nonmetastatic colorectal cancer.
We searched Medline, Embase, and CENTRAL databases through May 30, 2018.
We included randomized clinical trials evaluating intensive follow-up versus less follow-up in patients with nonmetastatic colorectal cancer.
Intensive follow-up.
Overall survival.
The analyses included 17 trials with a total of 8039 patients. Compared with less follow-up, intensive follow-up significantly improved overall survival in patients with nonmetastatic colorectal cancer after radical surgery (HR 0.85, 95% CI 0.74-0.97, P = 0.01; I2 = 30%; high quality). Subgroup analyses showed that differences between intensive-frequency and intensive-test follow-up (P = 0.04) and between short interval and long interval of follow-up (P = 0.02) in favor of the former one.
Clinical heterogeneity of interventions.
For patients with nonmetastatic colorectal cancer after curative resection, intensive follow-up strategy was associated with an improvement in overall survival compared with less follow-up strategy. Intensive-frequency follow-up strategy was associated with a greater reduction in mortality compared with intensive-test follow-up strategy.
结直肠癌手术后的强化随访在临床实践中很常见,但生存获益的证据有限。
对非转移性结直肠癌的随访策略的效果进行系统评价和荟萃分析。
我们检索了 Medline、Embase 和 CENTRAL 数据库,截至 2018 年 5 月 30 日。
我们纳入了评估非转移性结直肠癌患者强化随访与较少随访的随机临床试验。
强化随访。
总生存。
分析纳入了 17 项试验,共 8039 例患者。与较少随访相比,根治性手术后,强化随访显著改善了非转移性结直肠癌患者的总生存(HR 0.85,95%CI 0.74-0.97,P = 0.01;I2 = 30%;高质量)。亚组分析显示,强化频率和强化测试随访之间(P = 0.04)以及随访间隔长短之间(P = 0.02)存在差异,前者更有利。
干预措施的临床异质性。
对于根治性切除术后的非转移性结直肠癌患者,与较少的随访策略相比,强化随访策略与总体生存的改善相关。与强化测试随访策略相比,强化频率随访策略与死亡率的降低更相关。